Cosmoline

Quick links to important sections

Cosmoline

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cosmoline

Property Description
Active ingredient Petrolatum (Soft Paraffin)
Form Topical Ointment (Semi-solid)
Pharmacological class Dermatological Emollient and Protectant
General purpose Moisture retention and skin barrier support
Origin Derived (Purified Hydrocarbon Mixture)

Defining Cosmoline: Classification and Identity

Cosmoline is formally defined as a pharmaceutical preparation whose sole active component is Petrolatum, also recognized by the synonyms Petroleum Jelly or Soft Paraffin. This substance is categorized as a dermatological emollient and a high-level skin protectant, positioning it as a fundamental topical agent that operates exclusively on the skin's surface without systemic absorption. Petrolatum is primarily used as an occlusive dressing for its moisturizing effects. Cosmoline is a simple, single-ingredient product known for its high-purity profile, making it a frequent choice for sensitive skin patients.

Composition and Origin: The Essence of Purified Petrolatum

The preparation Cosmoline is administered as a semi-solid topical ointment composed fundamentally of Petrolatum, which functions as both the active entity and the semi-solid base/vehicle. This substance is a complex, purified mixture of saturated hydrocarbons derived through specialized petroleum refining processes, classifying its origin as derived rather than naturally sourced or fully synthetic. The high degree of purification ensures a chemically inert and hydrophobic substance suitable for use on the epidermis.

General Purpose: Protecting the Skin Barrier

The general purpose of Cosmoline is to reinforce and support the skin's capacity for moisture retention and defense against external stressors. This action is achieved through a biophysical principle known as occlusion, whereby the semi-solid forms a continuous, physical film over the skin. By creating this layer, Cosmoline dramatically reduces Transepidermal Water Loss (TEWL), ensuring the surface layers of the skin remain hydrated. This core mechanism directly benefits the patient by providing relief from general dryness, roughness, and flaking associated with an impaired skin barrier.

Regulatory References

  1. White Petrolatum USP Monograph
  2. DailyMed Label: PETROLEUM (White Petrolatum USP)

What side effects are possible with Cosmoline?

The official safety profile for Cosmoline, a preparation whose active ingredient is Petrolatum (Soft Paraffin), is defined by its classification as a non-systemically absorbed dermatological protectant, as documented in government regulatory sources, including the U.S. FDA Over-the-Counter Skin Protectant Monograph.

Adverse reactions, when they occur, are classified within the regulatory category of Skin and Subcutaneous Tissue Disorders. These events are typically localized to the application site, reflecting a potential individual intolerance to the product.

Official Adverse Reactions and Safety Classifications

Category Documented Adverse Event Safety Note
Localized Reactions Allergic contact dermatitis, skin irritation, burning, stinging. Primarily local, application-site events.
Rare/Serious Reactions Severe systemic allergic reaction (hypersensitivity). Documented as rare risk in regulatory summaries.

Systemic Safety: Due to the lack of systemic absorption, there are no officially documented serious adverse reactions related to internal organ systems, and regulatory documents do not specify safety adjustments for populations with renal or hepatic impairment.

Safety Restrictions: Official labeling includes administration-agnostic constraints. Cosmoline should not be applied to deep or puncture wounds, animal bites, or serious burns prior to a full medical evaluation. These restrictions ensure appropriate professional wound management.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Cosmoline (Petrolatum Topical Ointment) is defined by its role as a skin protectant that is not systemically absorbed. This confirms that no systemic pharmacological toxicity or overdose manifestations are documented for regular topical application. The recognized overdose profile is constrained solely to the risks associated with accidental oral ingestion.

Overdose Scenario and Mandated Action Official Regulatory Statement
Exposure Risk Overdose is officially documented only in the context of the accidental swallowing of the medicine.
Mandated Action You must get medical help or contact a Poison Control Center right away if the product is swallowed.
Severe Manifestations Should symptoms occur that include passing out or difficulty with trouble breathing following ingestion, the label mandates immediate contact with emergency medical services.
Antidote Status No specific antidote for accidental ingestion of this inert substance is documented in the official regulatory labeling.

Accidental oral ingestion is officially classified as an event that may be harmful, necessitating prompt professional medical assessment and monitoring. The regulatory warnings emphasize this risk by explicitly mandating that the product be kept out of reach of children, as this population is considered the highest risk for accidental exposure. Medical attention must be sought immediately whenever symptoms indicate severe distress.

Therapeutic Uses of Cosmoline

What Cosmoline Treats: Main Uses and Benefits

Therapeutic Scope and Supportive Care

The therapeutic role of Cosmoline (Petrolatum) centers on providing topical relief and supportive care across common dermatological challenges. Its therapeutic scope involves application across domains where additional symptomatic support is needed, primarily related to barrier function, environmental damage, and friction-induced irritation.


Cosmoline is commonly used for managing symptoms of persistent dry skin (xerosis) and generally serves as adjunctive care for conditions involving inflammatory or irritative processes, such as Eczema. It helps address symptom clusters that may become intense, specifically persistent roughness, scaling, flaking, and associated itching. The primary benefit contributes to improved comfort during periods of heightened symptoms and may help patients cope more steadily with symptom fluctuations.

“The primary benefit contributes to improved comfort during periods of heightened symptoms and supports the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Dryness and Irritation

Cosmoline is commonly used to help with conditions presenting with significant symptomatic burden, such as dry skin, chapping, minor scrapes, and diaper rash.


The medication is considered relevant in clinical settings that involve acute or disruptive symptom patterns, including chapped skin, windburn, chafing, minor cuts, and scrapes. It is considered relevant across patient groups, including infants and older adults, and provides support that helps ease the overall symptom burden in situations involving recurrent or episodic manifestations.

Regulatory References

  1. National Library of Medicine's DailyMed service

Eligibility and Restrictions for Use

The official regulatory profile for Cosmoline (Petrolatum) establishes broad eligibility across the general population due to its classification as a non-systemic, topical skin protectant under the U.S. FDA Over-The-Counter (OTC) Monograph.

Populations Allowed and Contraindicated

Use is established for all age groups, spanning infants, children, adults, and older adults; regulatory documents confirm its use for diaper rash prevention and treatment. Eligibility is unrestricted by systemic comorbidities such as severe hepatic or renal impairment, as the medicine is not absorbed internally.

The primary absolute prohibition is for individuals with a known hypersensitivity or allergy to petrolatum or any ingredient in the specific formulation.

Eligibility Restrictions

Regulatory labeling mandates strict limitations on application conditions. The product must not be used on specific injury types, including deep or puncture wounds, animal bites, or serious burns. For women who are breastfeeding, use is permitted but conditional: the product must not be applied to the breast area near the infant's mouth. Use is strictly limited to external skin application and contact with the eyes must be avoided.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cosmoline, a product whose active ingredient is Petrolatum (Soft Paraffin), has a specific interaction profile documented in official regulatory sources. Due to its status as an inert topical protectant with negligible systemic absorption, it does not participate in classic systemic pharmacokinetic interactions.

Regulatory labels confirm the absence of known interactions with liver CYP enzymes or drug transporters, which are the primary pathways for systemic drug-drug interactions.


The sole clinically relevant interaction domain is defined by its physical occlusive properties.

Official Interaction Statements

Interaction Type Interacting Substances Regulatory Implication/Constraint
Systemic Pharmacokinetics None documented No systemic drug-drug interactions are reported.
Localized Exposure Alteration Other Topical Medicinal Products Co-application may increase the localized absorption of the co-applied medicine.
Administration Timing Other Topical Preparations Requires separation in the timing of application to ensure the intended action of the co-applied product.

Official regulatory information does not document any interactions with food, alcohol, or herbal products. The interaction structure necessitates that constraints focus on the sequence of application when other topical preparations are used concurrently, avoiding any interpretation or advice beyond the label.

Mechanism of Action

The Mechanism of Cosmoline: Biophysical and Cellular Effects

Cosmoline's action is purely biophysical and peripheral, confined to the skin's surface without engaging molecular targets like receptors or enzymes. The mechanism involves forming a continuous, hydrophobic film across the Stratum Corneum, the outermost epidermal layer. This physical shield results in a passive blockade that significantly restricts the Transepidermal Water Loss (TEWL) pathway. This action facilitates the retention of water in the skin's surface layer, which is the initial step that modifies the localized physiological state of the epidermis.

This sustained hydration initiates structural organization signaling and secondary molecular changes. The resulting water retention maintains the structural integrity of the skin's intercellular lipid bilayers. This environmental shift acts as a stimulus for underlying keratinocytes, leading to the upregulation of key barrier proteins (like Filaggrin) and Antimicrobial Peptides (AMPs). This physiological modulation increases the mechanical strength of the epidermis and modulates the activity within its host-defense mechanisms.

Dosage and Administration Information

How to Use Cosmoline

Cosmoline (Petrolatum Ointment) is a medication for topical administration, meaning it is applied exclusively to the external surface of the skin. The use of this product is structured by administration patterns rather than a fixed, measured dose. The ointment is applied liberally to fully cover the affected area.

Application Frequency and Context

For general use in adults, application is determined by necessity, and is to be applied as needed or as often as necessary. There are no fixed time-of-day requirements, as the frequency is tied to the need for barrier support.

The application process involves a specific preparation step. Before the ointment is administered, the area of skin is cleansed and allowed to dry.

Population-Specific Use

For pediatric patients, a specific schedule is designated for the use of the ointment in the context of diaper rash. The product is applied with each diaper change, and application is recommended especially at bedtime or anytime when exposure to wetness may be prolonged. The duration of use is temporary and continues as long as the protective barrier is needed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cosmoline


Evidence for Use in Dry Skin (Xerosis) and Eczema

Cosmoline was studied for use in managing dry skin and as part of supportive care for Eczema, a condition characterized by fluctuating manifestations. Research was evaluated in varied study designs, including systematic reviews and randomized controlled trials. Studies monitored outcomes related to the formation of a physical, occlusive barrier on the skin surface, and research highlights measurements recorded, such as Transepidermal Water Loss (TEWL). When used for established Eczema, the effect of the single ingredient can be difficult to isolate, as formulations are often complex. Long-term outcomes related to the reduction in Eczema relapse rates over extended periods are not uniformly well-documented.


Evidence for Use in Diaper Rash

The research for this use was evaluated in settings involving neonates and infants using Randomized Controlled Trials (RCTs). These trials examined the incidence rate and the severity of the rash. The overall goal of this research was to explore how the substance compared against controls or existing care protocols. The regulatory status for this use was evaluated in the FDA OTC Monograph. However, follow-up durations were limited to short periods, and some studies focusing on primary prevention have reported mixed findings.


Evidence for Use in Minor Cuts and Abrasions

Cosmoline was studied for its role as a temporary protectant for minor cuts, scrapes, and abrasions. Comparative trials, often conducted in professional settings, examined outcomes such as healing rate and infection incidence. Studies monitored the formation of a physical, protective layer. The regulatory status was evaluated in the FDA OTC Monograph. Comparative evidence is lacking for the substance against all modern synthetic barrier films, and long-term outcomes related to scar formation are not well characterized.


What is Still Uncertain About Cosmoline

While research is substantial in many areas, evidence quality varies across studies, and some comparative evidence is lacking. Long-term outcomes are not fully established for some applications, and subgroup findings are uncertain when trying to isolate the effect of a single ingredient from a complex topical product. Research provides context but does not offer individual predictions.

Key Studies & References

  1. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review

Frequently Asked Questions (FAQ)

Common questions about Cosmoline (FAQ)

Q: How does Cosmoline differ from other medicines that treat the same condition?

A: Cosmoline is fundamentally a non-systemic product, meaning it works only on the skin's surface and is not absorbed into the bloodstream. It functions by forming a physical, occlusive barrier to support the skin. Official documents confirm that due to this mechanism, it is not involved in systemic pharmacokinetic interactions like many prescription medications that are absorbed internally.

Q: How long does it usually take to feel the effects of Cosmoline?

A: Since Cosmoline works by physically creating a protective, occlusive layer on the skin's surface to help retain moisture, the primary barrier effect itself is described as immediate upon application. The resulting physiological changes in the skin occur over time with consistent use.

Q: What official documents describe the proper storage for Cosmoline?

A: Details regarding the proper storage conditions for Cosmoline, such as temperature requirements and instructions to protect it from excessive heat, are published in the official FDA labeling. This information is often summarized in public resources like the DailyMed entry for the product.

Q: Are there different strengths or forms of Cosmoline?

A: Official labeling shows that the active ingredient, petrolatum, is used in various strengths and is incorporated into different topical forms, including both ointments and creams. These different formulations may include other inactive or active ingredients.

Q: Why does the packaging for Cosmoline include a special warning?

A: Official warnings are required on the packaging to help ensure safe use. These warnings inform users that the product is for external application only and identify that it should not be used on deep puncture wounds, animal bites, or serious burns without first seeking medical evaluation.

Q: What does 'Black Box Warning' mean for a medicine like Cosmoline?

A: A Black Box Warning is a regulatory safety statement used for certain prescription drugs that carry significant risks. Cosmoline, as an Over-the-Counter (OTC) skin protectant with non-systemic use, does not carry this warning in its official product labeling.

Q: Why do official sources not recommend a specific lifestyle change with Cosmoline?

A: Official sources note the absence of documented interactions with food, alcohol, or herbal products. This lack of interaction is due to Cosmoline having negligible systemic absorption, meaning it does not enter the bloodstream and therefore is not expected to interfere with internal body processes.

Q: What does the term 'contraindication' mean for Cosmoline?

A: A contraindication refers to a specific condition where the product must not be used because the risk outweighs the potential benefit. For Cosmoline, the only absolute prohibition listed in official documents is a known hypersensitivity or allergy to petrolatum or any ingredient in the product.

Q: What research evidence supports the use of Cosmoline?

A: Research evidence primarily supports Cosmoline's role in forming an occlusive barrier on the skin's surface. This mechanism reduces Transepidermal Water Loss (TEWL), which in turn helps provide protection and moisture support for common conditions like dry skin, diaper rash, and minor wounds.

Q: What is the difference between an allergy and a common side effect of Cosmoline?

A: Official patient information often distinguishes between common localized reactions, such as minor irritation or stinging, and a serious allergic reaction. Serious allergic reactions may include symptoms like a widespread rash, significant swelling, or trouble breathing. The official warning indicates that these require immediate professional attention.

Q: Where can I find the official Patient Information Leaflet for Cosmoline?

A: The official product labeling, which includes patient information, can typically be accessed through governmental regulatory sources. These include the DailyMed website or the official product labeling archives provided by bodies like the FDA.

Q: Do I need a special blood test before starting Cosmoline?

A: Official regulatory documents do not mention any special blood tests that are required before starting the use of Cosmoline. This is consistent with its classification as a topical agent with negligible systemic absorption.

Q: Is it normal to feel tired or dizzy when first taking Cosmoline?

A: Official product labeling does not list systemic effects such as tiredness or dizziness as documented adverse reactions. This aligns with its topical route of administration and lack of absorption into the main body system.

Q: What should I do if I miss a dose of Cosmoline?

A: The regulatory directions for Cosmoline state to 'apply as needed,' rather than following a strict schedule. Because of this, there is no fixed dose or application time that can be missed.

Q: Does Cosmoline affect my ability to drive or operate machinery?

A: Official labeling for Cosmoline does not contain warnings about effects on driving or operating heavy machinery. This is expected given its non-systemic, topical use.

Q: What happens if I accidentally take two doses of Cosmoline?

A: Official labeling advises users to keep the product out of reach of children. If the product is swallowed, the label advises seeking medical help or contacting a Poison Control Center right away.

Q: What should I ask my pharmacist about Cosmoline?

A: Official patient information highlights that a pharmacist is a resource for discussing all ingredients in the product, confirming any known allergies, and reviewing specific storage instructions for the brand being used.

Q: Can I stop taking Cosmoline suddenly?

A: Regulatory guidance instructs users to 'apply as needed.' Stopping the use of a product applied on this basis is not associated with a specific withdrawal risk in the official warnings.

Q: How does the time of day I take Cosmoline impact its effectiveness?

A: Official directions for use state to 'apply as needed,' which indicates that the application time is based on the patient's need for barrier support, rather than a fixed time of day, to maximize its effectiveness.

Q: Is Cosmoline known to cause hair loss?

A: Official adverse event reporting for Cosmoline, as documented in regulatory sources, does not list hair loss as a documented adverse reaction.

Q: What is the general expectation for improvement with Cosmoline?

A: Official guidance identifies that use should be stopped if the condition worsens or if symptoms last more than seven days. This regulatory timeframe provides an expectation for when professional attention is needed.

Q: Is it possible to be allergic to the inactive ingredients in Cosmoline?

A: Yes, official safety notes advise that any product, including Cosmoline, may contain inactive ingredients which can potentially cause allergic reactions in some individuals. Official safety information advises patients to be aware of all ingredients in the product.

Q: How does Cosmoline affect blood pressure or heart rate?

A: Cosmoline is classified as a non-systemically absorbed topical protectant. Because of this, official safety documents do not list any documented effects on internal vital signs such as blood pressure or heart rate.

Q: What are the typical reasons a doctor would stop prescribing Cosmoline?

A: Official warnings identify that the user should stop use and ask a doctor if the condition worsens or if symptoms clear up and occur again within a few days. These scenarios represent common reasons for professional re-evaluation.

Q: What should I do if my side effects from Cosmoline get worse?

A: The official warning section of the labeling states that use should be stopped if the condition worsens. This is the regulatory action for when localized symptoms escalate.

Q: Can Cosmoline be taken with antacids or heartburn medicine?

A: Official documents state that Cosmoline does not participate in systemic pharmacokinetic interactions. Since antacids and heartburn medicines are internal treatments, it is not anticipated to cause systemic conflict.

Q: How long does Cosmoline stay in my system after I stop taking it?

A: Official sources state that Cosmoline has negligible systemic absorption, meaning it does not enter the internal system in measurable amounts. Therefore, it does not remain in the body system after use.

Q: What are the steps if I suspect an interaction between Cosmoline and another medicine?

A: Official interaction statements for other topical products require separation in the timing of application. In the regulatory context, when concerns about systemic interactions arise, professional medical guidance is generally advised.

Q: Is it okay to take over-the-counter cold medicine with Cosmoline?

A: Official documents state that there are no known systemic drug-drug interactions with Cosmoline. Due to the absence of known systemic drug-drug interactions, internal medicines are generally not of concern regarding interaction with Cosmoline.

Q: Are the listed side effects for Cosmoline rare or common?

A: Serious adverse reactions, such as a severe systemic allergic reaction, are documented as a rare risk. Conversely, minor localized reactions like skin irritation, burning, or stinging are noted as common localized effects in official documents.

How should Cosmoline be stored and disposed of?

The storage and disposal of Cosmoline (Petrolatum USP) are governed by regulations focused on maintaining product stability and ensuring safety.

Storage Conditions

Labeled Storage Temperature: Store at room temperature (20 C to 25 C / 68 F to 77 F) [DailyMed].
Protection Requirements: Avoid excessive heat and humidity to prevent the ointment from melting and degrading. Protection from light is also required [DailyMed].
Packaging Rules: The container must be kept tightly closed when not in use to prevent contamination.
Child-Protection: Keep out of reach of children. Contact Poison Control immediately if the product is swallowed [DailyMed].

Disposal Instructions

Disposal must adhere to local regulations and environmental safety measures. The product is not on the FDA's flush list and must not be poured down drains or flushed down the toilet.

Unused or expired product should be mixed with an undesirable substance (such as dirt) and placed in a sealed container before being thrown into the household trash, following FDA-recommended disposal guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cosmoline found in:

A-Z Index: